BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 36983082)

  • 1. The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease.
    Kourtidou C; Tziomalos K
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.
    Kato M; Natarajan R
    Nat Rev Nephrol; 2019 Jun; 15(6):327-345. PubMed ID: 30894700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modification in diabetic kidney disease.
    Liu Z; Liu J; Wang W; An X; Luo L; Yu D; Sun W
    Front Endocrinol (Lausanne); 2023; 14():1133970. PubMed ID: 37455912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium Butyrate Attenuates Diabetic Kidney Disease Partially via Histone Butyrylation Modification.
    Zhou T; Xu H; Cheng X; He Y; Ren Q; Li D; Xie Y; Gao C; Zhang Y; Sun X; Xu Y; Huang W
    Mediators Inflamm; 2022; 2022():7643322. PubMed ID: 35909658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
    Zheng W; Guo J; Liu ZS
    Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress as a culprit in diabetic kidney disease.
    Su S; Ma Z; Wu H; Xu Z; Yi H
    Life Sci; 2023 Jun; 322():121661. PubMed ID: 37028547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Acetylation and Its Modifiers in the Pathogenesis of Diabetic Nephropathy.
    Li X; Li C; Sun G
    J Diabetes Res; 2016; 2016():4065382. PubMed ID: 27379253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances.
    Watanabe K; Sato E; Mishima E; Miyazaki M; Tanaka T
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis.
    Sun J; Wang Y; Cui W; Lou Y; Sun G; Zhang D; Miao L
    J Diabetes Res; 2017; 2017():7242384. PubMed ID: 28695133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic kidney diseases revisited: A new perspective for a new era.
    Fu H; Liu S; Bastacky SI; Wang X; Tian XJ; Zhou D
    Mol Metab; 2019 Dec; 30():250-263. PubMed ID: 31767176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules.
    Tang J; Liu F; Cooper ME; Chai Z
    Expert Opin Ther Targets; 2022 Aug; 26(8):721-738. PubMed ID: 36217308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA H19: a novel player in the regulation of diabetic kidney disease.
    Wu Q; Huang F
    Front Endocrinol (Lausanne); 2023; 14():1238981. PubMed ID: 37964955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.
    Hirakawa Y; Tanaka T; Nangaku M
    J Diabetes Investig; 2017 May; 8(3):261-271. PubMed ID: 28097824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGE/RAGE in diabetic kidney disease and ageing kidney.
    Wu XQ; Zhang DD; Wang YN; Tan YQ; Yu XY; Zhao YY
    Free Radic Biol Med; 2021 Aug; 171():260-271. PubMed ID: 34019934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Histone Modifications in Kidney Fibrosis.
    Pan S; Yuan T; Xia Y; Yu W; Zhou X; Cheng F
    Medicina (Kaunas); 2024 May; 60(6):. PubMed ID: 38929505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Contribution to Inflammation in Diabetic Kidney Disease.
    Mitrofanova A; Fontanella AM; Burke GW; Merscher S; Fornoni A
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria in Diabetic Kidney Disease.
    Ahmad AA; Draves SO; Rosca M
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, oxidative stress, apoptosis, and autophagy in diabetes mellitus and diabetic kidney disease: the Four Horsemen of the Apocalypse.
    Turkmen K
    Int Urol Nephrol; 2017 May; 49(5):837-844. PubMed ID: 28035619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: a systematic review and meta-analysis.
    Dai Y; Quan J; Xiong L; Luo Y; Yi B
    Ren Fail; 2022 Dec; 44(1):862-880. PubMed ID: 35611435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of protein kinase STK25 ameliorates renal lipotoxicity and protects against diabetic kidney disease.
    Cansby E; Caputo M; Gao L; Kulkarni NM; Nerstedt A; Ståhlman M; Borén J; Porosk R; Soomets U; Pedrelli M; Parini P; Marschall HU; Nyström J; Howell BW; Mahlapuu M
    JCI Insight; 2020 Dec; 5(24):. PubMed ID: 33170807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.